MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from the sale of
common stock, net of...
$215,721K
Stock-based compensation
expense
$45,846K
Net income (loss)
$20,890K
Proceeds from exercise of
stock options
$17,202K
Proceeds from exercise of
common stock and...
$5,187K
Other liabilities
$14,139K
Change in fair value of
contingent consideration
$5,536K
Accrued compensation
$4,901K
Accounts payable
$3,612K
Depreciation and
amortization
$2,017K
Non-cash lease expense
$607K
Amortization of debt issuance
costs
$35K
Other non-cash
reconciling items
-$17K
Net cash provided by
financing activities
$137,161K
Net cash provided by
(used in) operating...
$46,798K
Canceled cashflow
$100,949K
Canceled cashflow
$50,802K
Net increase
(decrease) in cash and cash...
-$17,822K
Canceled cashflow
$183,959K
Maturities of marketable
securities
$254,068K
Payment for repurchase
of common stock
$100,146K
Tax withholding
payments for net...
$741K
Payment of debt issuance
costs
$62K
Accounts receivable
$28,208K
Inventory
$14,031K
Prepaid expenses, other
current assets and other...
$4,738K
Accretion of
premium/discount on marketable...
$3,517K
Operating lease
liabilities
-$308K
Net cash used in
investing activities
-$201,781K
Canceled cashflow
$254,068K
Purchases of marketable
securities
$455,776K
Purchases of property and
equipment
$73K
Back
Back
Cash Flow
source: myfinsight.com
SOLENO THERAPEUTICS INC (SLNO)
SOLENO THERAPEUTICS INC (SLNO)